Intellectual Property India Publishes Patent Application for 'Phosphatidylinositol 3- Kinase (PI3K) And Phosphatase And Tensin Homolog (PTEN) Expression In Breast Cancer And Its Correlation With Clinicopathological Prognostic Markers' Filed by Adichunchanagiri University; and Adichunchanagiri Institute Of Medical Sciences

MUMBAI, India, May 29 -- Intellectual Property India has published a patent application (202641062351 A) filed by Adichunchanagiri University; and Adichunchanagiri Institute Of Medical Sciences, Mandya, Karnataka, on May 16, for 'phosphatidylinositol 3- kinase (pi3k) and phosphatase and tensin homolog (pten) expression in breast cancer and its correlation with clinicopathological prognostic markers.'

Inventor(s) include Dr. Prescila Christopher; and Dr. Amita K.

The application for the patent was published on May 29, under issue no. 22/2026.

According to the abstract released by the Intellectual Property India: "The present invention proposes a novel dual-biomarker immunohistochemical assessment system and method, termed the PI3K-PTEN In...